Fast Growing Techbio: Data, Computational Research, IP and How to Leverage Those for Commercial Success

On Wednesday 6 May we were delighted to co-host a panel discussion and networking event: “Fast growing techbio: data, computational research, IP and how to leverage those for commercial success” at our London office in partnership with Wolf Greenfield.

The event brought together stakeholders from across the techbio and life sciences ecosystem to explore how companies can harness data-driven innovation and align their IP strategies to support commercial growth. We were joined by a panel of highly experienced contributors with backgrounds spanning entrepreneurship, investment, and IP strategy. Camille Terfve moderated an engaging and wide-ranging discussion, alongside panellists: Hakim Yadi Ph.D. OBE – Partner, Pharmaceuticals & Life Sciences at Baringa Management Consultants, Liz Elmhirst – VP of IP at Cora Biosciences and Dan Rudoy – Shareholder at Wolf Greenfield.

The panel explored key themes including the definition and rapid growth of techbio, the central importance of data as a commercial asset, and the practical challenges of protecting that data through a combination of patents, trade secrets and contractual arrangements. A particularly valuable aspect of the session was the use of practical examples drawn from the panellists’ own experience. These illustrated how IP strategies evolve as companies scale, how to balance disclosure with protection when engaging with investors and partners, and the realities of collaboration agreements in fast-moving, data-rich environments. 

As the evening continued, guests continued the conversation over drinks and canapés in a relaxed networking session, with panoramic views across the London skyline. This provided an excellent opportunity for in-depth discussions between attendees and panellists.